ICRP 123: Fe56 - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz Fe56. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of heavy ion.xls, sheet Fe56
Znormalizowana macierz danych ICRP 123 dla cząstki Fe56: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 4392 z 4392 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 98.7 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 89.1 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 108 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8910 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 1 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 197 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 178 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 216 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17800 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21600 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 2 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 295 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 267 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 324 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26700 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32400 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 3 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 492 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 444 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 540 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44400 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54000 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 5 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1150 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1100 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1190 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.4 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.6 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 822 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 991 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.86 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.65 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88500 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.6 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 209 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.4 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.2 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.21 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 10 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1620 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1560 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1680 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.5 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.28 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1420 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.126 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.109 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.134 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.141 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.149 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.109 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1750 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.138 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.135 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.316 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.232 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.4 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.5 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.176 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.184 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.4 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.231 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23.4 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 293 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.128 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.12 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.117 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.179 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.8 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.125 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.203 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0901 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.124 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.111 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.17 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.145 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.326 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.16 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.16 |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 14 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2370 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2310 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2430 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23.3 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.5 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2670 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2670 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.52 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.573 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.535 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.585 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.422 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.594 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2730 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.271 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.543 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.534 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.376 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.416 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.482 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.724 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.428 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.645 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.7 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.706 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.675 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.54 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174000 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 210000 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 223 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.3 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.458 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.57 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2600 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 370 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.546 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.408 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.502 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.497 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.511 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.495 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.89 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13.6 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.608 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.21 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.411 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.525 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.393 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.634 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.543 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.493 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.364 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.56 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.929 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.6 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.6 |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 3690 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 3650 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 3720 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.4 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5380 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.03 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.9 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.94 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.76 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.02 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3950 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.12 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.77 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.92 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.72 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.96 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.84 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.01 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.42 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.9 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.45 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.87 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94.1 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.64 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 255000 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 307000 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 372 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.2 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.19 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.62 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4280 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.62 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.42 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.71 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.88 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.61 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.65 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 264 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.65 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 269 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.3 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.75 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.42 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.66 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.58 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.4 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.81 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.83 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.76 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.84 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.87 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.24 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54 |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 30 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6810 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6920 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6700 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.5 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.1 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17900 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16600 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.1 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.9 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.83 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.48 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.8 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8350 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.95 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.5 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.4 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.55 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.27 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.6 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.3 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.8 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.2 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 281 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.7 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.7 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.6 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.7 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399000 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467000 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 710 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.31 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.34 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7760 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.67 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.39 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.76 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.74 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.79 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.43 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 800 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.9 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.5 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.1 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.5 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.9 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.94 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.59 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.16 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.78 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.24 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.72 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.1 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.9 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.6 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 217 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 217 |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 14000 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 16400 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 11700 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 233 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85400 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62100 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.8 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.6 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.9 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.9 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21100 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.9 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.4 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95.4 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 672 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 221 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.1 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6400 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 286 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407000 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420000 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1930 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 290 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.8 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18100 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2550 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27.8 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.9 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27.2 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4810 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.1 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1800 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.2 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.5 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.8 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.7 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.8 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.6 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.3 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.6 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.4 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.2 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 333000 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 333000 |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 75 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 22000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 27100 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 17000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 627 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94.4 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36300 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.8 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.3 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 218 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 280 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.9 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 169 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1790 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28100 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4680 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 354000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 354000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4200 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 966 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.3 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.3 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34400 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7180 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.5 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.1 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93.9 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.9 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.3 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13300 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5760 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1600 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 318 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2180 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.1 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.9 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.3 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.5 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.2 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397000 |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 37400 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 46900 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 27900 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7190 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8070 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 283000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 179000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 715 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74800 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 386 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6450 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10400 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 347 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14100 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18600 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17700 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 787 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49100 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 278000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 277000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13300 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7060 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 343 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 334 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85800 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36600 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 332 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 361 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 365 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 390 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34700 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16200 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32100 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12400 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10200 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19300 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 261 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 354 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 276 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 311 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 371 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7600 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4100 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304000 |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 150 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 49700 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 57900 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 41600 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 289000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 218000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3310 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4110 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2550 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2220 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2930 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 880 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2170 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3410 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3190 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1590 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55900 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 838 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50300 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57700 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10900 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20500 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 238000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 240000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23400 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16300 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 874 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 977 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64400 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 949 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 896 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 935 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 972 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51800 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71800 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42100 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33600 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 788 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 967 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 811 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 862 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31200 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21600 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 237000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 237000 |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 200 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 82600 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 85300 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79900 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54900 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57800 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 257000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 231000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53700 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38200 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51500 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31100 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2620 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31200 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49200 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27300 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28100 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19300 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77300 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97500 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 171000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 213000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49100 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46900 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4090 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3380 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88500 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3090 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32100 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6960 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68800 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2460 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3780 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2590 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2780 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23200 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19900 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45400 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247000 |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Fe56 | Fe-56 | 26 | 56 | 300 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 178000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 191000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71900 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96100 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90900 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 196000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 207000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97600 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 222000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91100 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97200 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 184000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 221000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 209000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41300 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73200 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81500 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 206000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 206000 |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 500 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 168000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 179000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 192000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 187000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 200000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 193000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 192000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 217000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 218000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 205000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 212000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 204000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 168000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 204000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 202000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 185000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 200000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 202000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 216000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 216000 |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 700 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 148000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 148000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 170000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 169000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 178000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 1000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97800 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89400 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97700 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92900 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91700 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95400 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95100 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96600 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98500 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97700 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87200 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95900 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82300 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91200 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94700 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99500 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.4 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.5 | |
| Fe56 | Fe-56 | 26 | 56 | 2000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97700 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91500 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98900 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95600 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93200 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92900 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94900 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92700 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95600 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95200 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89700 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96300 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97600 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Fe56 | Fe-56 | 26 | 56 | 3000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 124000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94200 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 162000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96100 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Fe56 | Fe-56 | 26 | 56 | 5000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99100 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96900 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Fe56 | Fe-56 | 26 | 56 | 10000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 162000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 176000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194000 |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Fe56 | Fe-56 | 26 | 56 | 20000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 167000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 162000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 197000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 164000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 169000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 168000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 171000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 176000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 171000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 204000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 200000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 185000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 176000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 162000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Fe56 | Fe-56 | 26 | 56 | 50000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 193000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 188000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 192000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 223000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 210000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 193000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 184000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 191000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 184000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 188000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 171000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 203000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 197000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 188000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 212000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 227000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 220000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 185000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 183000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 179000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 183000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 193000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 191000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 207000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 176000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 187000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 179000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 183000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 182000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 188000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 184000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195000 |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Fe56 | Fe-56 | 26 | 56 | 100000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 |